5 ASX Stocks Under $5 You Can Buy Today!
We hear it over and over from investors like you…
"If only I had bought Pro Medicus or Netflix when they were first recommended by the Motley Fool, I'd be sitting on a gold mine right now!"
And it's true! But, with the recent explosion of interest in the stock market, we believe it's more important than ever to remember why we're long-term-focused investors:
Just think… had you invested in Pro Medicus back in March 2015, when we sent a "buy alert" at $1.48 per share, you'd be up 4,089% right now…
Or if you had invested in Netflix on 26 July, 2012 when we recommended it at $US8.42 per share, you'd be up 7,786%.
Those are actual investment recommendations that have been shared with our loyal Motley Fool members over the years — and while we're incredibly proud of big winners like these, we know that not every stock we recommend will be such a huge winner (or even a winner at all)…
That's why we recommend diversifying your portfolio and buying a wide range of companies with immense upside potential – including one under-the-radar ASX software company that recently caught the attention of some of our top analysts and investors…
Will this be our next 5X+ winner?
Of course, when it comes to investing there are never any guarantees – and only time will tell what will happen with this ultra-promising little company…
But you should know that many of the very same analysts who stumbled onto this up-and-coming ASX company also recommended a then-little-known U.S. software company called DocuSign to members of our U.S.-focused Shooting Stars service back on 30 May, 2019…
And had you followed their advice and purchased shares at the time, today you'd already be up 343%.
That's a gain of more than 4X in just two and a half years!
[Source: S&P Capital IQ]
Perhaps even more incredible, though, is that these very same analysts and investors believe that the tiny ASX software company we're talking about today could be following closely in the footsteps of DocuSign – despite being less than 1/50th its size!
For instance, both companies are:
- Squarely focused on completely disrupting long-standing "business-as-usual" practices and making it possible for their users to work 100% remotely by offering easy-to-use subscription-based services…
- Allowing their users to save both valuable time and costly resources while doing business in a far more efficient manner across countless sectors and industries (including finance… healthcare… legal… telecom… and resources – just to name a few!)…
- Making their revolutionary offerings available to both individuals and large-multi-national corporations (in fact, despite its small size this company serves over 12,000 business clients including giants like ExxonMobil, United-Health Group, BNY Mellon, T-Mobile, Caterpillar and most recently, Jeff Bezos' space company, Blue Origin!)…
Yet, whereas DocuSign trades on U.S. markets only, you can buy shares of this breakout Australian company right here on the ASX for less than $5!
As a matter of fact, this company is just one of five ASX companies that's detailed in an in-depth research report we recently released called, "5 Stocks Under $5 You Can Buy Today" – which for a limited time only we're making available to investors like you absolutely free of charge.
All you have to do to claim your free copy is simply enter your email address in the box just below and let us know where you'd like for us to send it.
When you do, you'll not only discover the full details on the tiny ASX tech outfit we believe has the potential to be our next 5X+ winner, but also four more under-the-radar shares we believe have huge profit potential – all of which are selling for under $5 a share right now!
So, if you've ever regretted missing out on big winners like ProMedicus, Netflix, or DocuSign, we'd urge you to enter your email below to claim your free report right away!
Enter Your Email Address:
Returns as of 30 November 2021. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended DocuSign and Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended Netflix. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. For more information about The Motley Fool see our Financial Services Guide. Please remember that investments can go up and down. Past performance is not necessarily indicative of future returns. Performance figures are not intended to be a forecast and The Motley Fool does not guarantee the performance of, or returns on any investment. Any money back guarantee is strictly limited to the subscription price paid for the product.